Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MAXLINEAR, INC Director's Dealing 2023

Feb 8, 2023

31984_dirs_2023-02-07_d23c133c-753a-4cdd-ae1b-e602447934fd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MAXLINEAR, INC (MXL)
CIK: 0001288469
Period of Report: 2023-02-03

Reporting Person: Kwong Connie H. (Corporate Controller & PAO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-03 Common Stock A 3601 Acquired 33887 Direct
2023-02-06 Common Stock F 2112 $38.87 Disposed 31775 Direct
2023-02-06 Common Stock A 1906 Acquired 33681 Direct
2023-02-06 Common Stock F 992 $38.87 Disposed 32689 Direct
2023-02-06 Common Stock A 1271 Acquired 33960 Direct
2023-02-06 Common Stock F 667 $38.87 Disposed 33293 Direct
2023-02-06 Common Stock A 378 Acquired 33671 Direct
2023-02-06 Common Stock F 198 $38.87 Disposed 33473 Direct
2023-02-06 Common Stock A 252 Acquired 33725 Direct
2023-02-06 Common Stock F 132 $38.87 Disposed 33593 Direct

Footnotes

F1: Represents shares of Common Stock issued to the Reporting Person for the 2022 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 3, 2023.

F2: On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023.

F3: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on May 20, 2021. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023.

F4: Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on January 3, 2022. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. On February 6, 2023, the deferred shares of Common Stock were delivered to the Reporting Person. Shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) are based on the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 6, 2023.